Dennis Ding Stock Analyst Profile - Jefferies Research Coverage - Stocknear

Dennis Ding

Stock Analyst at Jefferies

(1.94)
# 3301
Out of 5,475 analysts
21
Total ratings
Success rate
Average return
17 Stocks
Name Action PT Current % Upside Ratings Updated
MLYS Mineralys Therapeuti...
Maintains: Hold
15 26
38.56 -32.57% 2 Sep 3, 2025
INDV Indivior
Assumes: Buy
20
24.39 -18% 1 Jul 22, 2025
CRNX Crinetics Pharmaceut...
Upgrades: Buy
55
35 57.14% 1 Jan 22, 2025
IKT Inhibikase Therapeut...
Initiates Coverage On: Buy
8
1.54 419.48% 1 Nov 8, 2024
ASMB Assembly Biosciences
Upgrades: Buy
2 35
22.26 57.23% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
7.94 126.7% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 7
4.62 51.52% 2 Sep 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
8 6
4.54 32.16% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
500 25
6.41 290.02% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
648
5.32 12080.45% 1 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 22
71.62 -69.28% 1 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
26.9 -10.78% 1 Dec 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
29.06 3.23% 1 Feb 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
2.18 1046.79% 1 Jan 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
195 52
22.47 131.42% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
13.77 -27.38% 1 Oct 26, 2021